GGNDF (GN Store Nord AS) 3-Year RORE % : -98.40% (As of Mar. 2026)


GGNDF GN Store Nord AS GGNDF
72 GF Score
Price $13.39
GF Value $15.84
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is GN Store Nord AS 3-Year RORE %?

GN Store Nord AS GGNDF 72 3-Year RORE % is -98.40 as of Mar. 2026. GuruFocus rates GGNDF with a GF Score™ of 72/100 and a GF Value™ of $15.84 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 782 Medical Devices & Instruments companies, GN Store Nord AS ranks worse than 91.69% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. GN Store Nord AS's 3-Year RORE % for the quarter that ended in Mar. 2026 was -98.40%.

The industry rank for GN Store Nord AS's 3-Year RORE % or its related term are showing as below:

GGNDF's 3-Year RORE % is ranked worse than
91.69% of 782 companies
in the Medical Devices & Instruments industry
Industry Median: -4.31 vs GGNDF: -98.40

GN Store Nord AS  (OTCPK:GGNDF) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


GN Store Nord AS 3-Year RORE % Related Terms


GN Store Nord AS 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for GN Store Nord AS's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GN Store Nord AS 3-Year RORE % Chart

GN Store Nord AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.49 -28.11 -78.81 28.94 25.26

GN Store Nord AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.53 20.98 11.30 25.26 -98.40

GGNDF vs ABT, SYK, MDT: 3-Year RORE % Comparison

For the Medical Devices subindustry, GN Store Nord AS's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GN Store Nord AS 3-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GN Store Nord AS's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where GN Store Nord AS's 3-Year RORE % falls into.


GGNDF
72GF Score
GN Store Nord AS GGNDF
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GN Store Nord AS 3-Year RORE % Calculation

GN Store Nord AS's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.391-0.531 )/( 0.937-0 )
=-0.922/0.937
=-98.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -98.40 mean?
GN Store Nord AS (GGNDF) has a 3-Year RORE % of -98.40 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on GN Store Nord AS and its competitors. According to the industry distribution chart, GN Store Nord AS ranks #717 out of 782 companies in the Medical Devices & Instruments industry, placing it in the top 91.7%.
Is GN Store Nord AS's 3-Year RORE % too high?
GN Store Nord AS's current 3-Year RORE % is -98.40. Based on the distribution chart, GN Store Nord AS ranks #717 out of 782 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, GN Store Nord AS has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GN Store Nord AS's 3-Year RORE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, GN Store Nord AS ranks #717 out of 782 companies for 3-Year RORE %. This places GN Store Nord AS in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on GN Store Nord AS and its competitors. GN Store Nord AS's current 3-Year RORE % is -98.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GN Store Nord AS stock overvalued right now?
Based on GuruFocus' analysis, GN Store Nord AS (GGNDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $15.84, compared to a current price of $13.39 — trading 15.5% below its estimated fair value. The current 3-Year RORE % is -98.40. GN Store Nord AS's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For GN Store Nord AS (GGNDF), the current 3-Year RORE % is -98.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GN Store Nord AS (GGNDF) Overvalued in 2026?

Based on GuruFocus' analysis, GN Store Nord AS stock appears to be undervalued. The current stock price of $13.39 is trading 15.5% below its estimated GF Value™ of $15.84. GuruFocus considers GN Store Nord AS to be Modestly Undervalued.

Key valuation signals for GGNDF:

  • 3-Year RORE %: -98.40
  • GF Value™: $15.84 vs. price of $13.39 (15.5% below fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the GGNDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GN Store Nord AS Business Description

Address Lautrupbjerg 7, Ballerup, DNK, 2750
GN Store Nord is a Danish company offering medical and audio solutions. The group comprises three businesses: hearing (about 40% of sales), enterprise (40%), and gaming (20%). GN Hearing offers hearing aids and competes globally with Sonova, Demant, Starkey, and WS Audiology (formerly Sivantos and Widex). GN Enterprise provides headsets and speakerphones to the enterprise market, including contact centers and offices. GN recently acquired SteelSeries, a provider of gaming accessories such as headsets and keyboards, thereby forming the gaming division. The company has positioned itself as a major player in the Unified Communication-enabled headsets market. The firm's premium brands are Resound in hearing, Jabra in headsets, and SteelSeries in gaming.
72GF Score

Get the complete analysis for GGNDF

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.39
Price
$15.84
GF Value